BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 722727)

  • 1. Stereoselective effects of cis- and trans-cyclopropylbis (dioxopiperazines) related to ICRF-159 on metastases of hamster lung adenocarcinoma.
    Witiak DT; Lee HJ; Goldman HD; Zwilling BS
    J Med Chem; 1978 Dec; 21(12):1194-7. PubMed ID: 722727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of stereoisomers related to ICRF-159 on metastasis of B16 melanoma.
    Zwilling BS; Campolito LB; Reiches NA; George T; Witiak DT
    Br J Cancer; 1981 Oct; 44(4):578-83. PubMed ID: 7295515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of (+/-) 1,2-bis(3,5-dioxopiperazin-1-yl) propane (ICRF 159) on liver metastases from a hamster lymphoma.
    Atherton A
    Eur J Cancer (1965); 1975 Jun; 11(6):383-8. PubMed ID: 1174351
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of ICRF 159 and trition WR 1339 on metastases of a rat epithelioma.
    Pimm MV; Baldwin RW
    Br J Cancer; 1975 Jan; 31(1):62-7. PubMed ID: 1156509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of trans-cyclopropylbis (diketopiperazine) and chelating agents related to ICRF 159. Cytotoxicity, mutagenicity, and effects on scheduled and unscheduled DNA synthesis.
    Witiak DT; Lee HJ; Hart RW; Gibson RE
    J Med Chem; 1977 May; 20(5):630-5. PubMed ID: 857019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the protective effect of ICRF-187 and structurally related analogues against acute daunorubicin toxicity in Syrian golden hamsters.
    Herman EH; el-Hage AN; Creighton AM; Witiak DT; Ferrans VJ
    Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):39-55. PubMed ID: 3922023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of high dose diethylstilbestrol and ICRF-159 on the growth and metastases of the R3327 MAT-LyLu prostate-derived tumor.
    Heston WD; Kadmon D; Fair WR
    Cancer Lett; 1981 Jul; 13(2):139-45. PubMed ID: 7306951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lewis lung carcinoma lines with different metastatic behavior: response to ICRF-159.
    Zupi G; Cavallari A; Greco C; Sacchi A
    Anticancer Res; 1984; 4(1-2):91-5. PubMed ID: 6712181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimetastatic effects of razoxane in a rat osteosarcoma model.
    Wingen F; Spring H; Schmähl D
    Clin Exp Metastasis; 1987; 5(1):9-16. PubMed ID: 3470164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of AT1727 on growth and metastasis of murine tumours.
    Li XT; Hutchinson GE; Pym BA; Finch M; Hellmann K
    Eur J Cancer Clin Oncol; 1983 Feb; 19(2):283-7. PubMed ID: 6681774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further evaluation of bimolane and analogs as potential antitumor agents.
    Ren YF; Otter GM; Schmid FA
    Eur J Cancer Clin Oncol; 1985 Apr; 21(4):493-7. PubMed ID: 3859415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICRF 159, (+/-) 1,2-di(3,5-dioxopiperazin-1-yl) propane NSC-129,943; razoxane.
    Bakowski MT
    Cancer Treat Rev; 1976 Jun; 3(2):95-107. PubMed ID: 821609
    [No Abstract]   [Full Text] [Related]  

  • 13. Interference with in vivo growth and metastasis of prostate adenocarcinoma (PA-III) by ICRF-159.
    Pollard M; Burleson GR; Luckert PH
    Prostate; 1981; 2(1):1-9. PubMed ID: 7279810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of radiation and razoxane (ICRF 159) in vivo.
    Hellmann K; Grimshaw MB; Hutchinson GE
    Int J Radiat Oncol Biol Phys; 1978; 4(1-2):109-13. PubMed ID: 632139
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of DTIC, DM-COOK and ICRF-159 on the number of circulating Lewis lung carcinoma cells detected by flow cytometry.
    Giraldi T; Sava G; Cherubino R; Bottiroli G; Mazzini G
    Clin Exp Metastasis; 1984; 2(2):151-9. PubMed ID: 6543695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of experimental lung metastases by cultured B16 melanoma cells treated with (+/-)-1,2-bis(3,5-dioxopiperazin-1-y)propane (ICRF-159).
    Lazo JS; Ingber DE; Sartorelli AC
    Cancer Res; 1978 Aug; 38(8):2263-70. PubMed ID: 667822
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis and characterization of the biological activity of the cisplatin analogs, cis-PtCl(2)(dexrazoxane) and cis-PtCl(2)(levrazoxane), of the topoisomerase II inhibitors dexrazoxane (ICRF-187) and levrazoxane (ICRF-186).
    Hasinoff BB; Wu X; Yang Y
    J Inorg Biochem; 2004 Apr; 98(4):616-24. PubMed ID: 15041241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological properties of ICRF-159 and related bis(dioxopiperazine) compounds.
    Herman EH; Witiak DT; Hellmann K; Waravdekar VS
    Adv Pharmacol Chemother; 1982; 19():249-90. PubMed ID: 6819768
    [No Abstract]   [Full Text] [Related]  

  • 19. ICRF-187 in clinical oncology.
    Poster DS; Penta JS; Bruno S; Macdonald JS
    Cancer Clin Trials; 1981; 4(2):143-6. PubMed ID: 6788388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of melphalan, ICRF-159, and hydroxyurea in metastatic prostate cancer: a preliminary report.
    Kvols LK; Eagan RT; Myers RP
    Cancer Treat Rep; 1977; 61(2):311-2. PubMed ID: 326400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.